{"id":"W4403223759","doi":"10.2139/ssrn.4966929","title":"Bevacizumab Beyond Progression: Impact of Subsequent Bevacizumab Re-Treatment in Patients with Ovarian, Fallopian Tube, and Peritoneal Cancer after Progression","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Columbia College","funders":"","keywords":"Bevacizumab; Fallopian tube; Ovarian cancer; Medicine; Oncology; Fallopian tube cancer; Internal medicine; Gynecology; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004901791,0.0007732032,0.001135356,0.0004207895,0.0001274534,0.0001181194,0.0001995079,0.000454013,0.0001198522],"category_scores_gemma":[0.00001271604,0.000455232,0.0003753821,0.0002798511,0.0002250378,0.0001176954,0.000318948,0.003582283,0.000003861848],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.005031191,"about_ca_system_score_gemma":0.008511855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009775056,"about_ca_topic_score_gemma":0.002699202,"domain_scores_codex":[0.9951197,0.0001256931,0.0008469421,0.0007762419,0.0008973329,0.002234129],"domain_scores_gemma":[0.9985269,0.00002035469,0.0004450104,0.0003960006,0.0003001884,0.0003115638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02097476,0.00233275,0.829727,0.00160979,0.00325921,0.0009875149,0.003008253,0.00007381001,0.0004178935,0.00128543,0.00003886266,0.1362847],"study_design_scores_gemma":[0.02016425,0.03716952,0.8924188,0.02086359,0.002517572,0.002310721,0.001193757,0.0002768871,0.001703537,0.01906578,0.0004337126,0.001881862],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9712625,0.02531922,0.000003759217,0.0009295854,0.0003240048,0.001791945,0.0001297292,0.00004216545,0.0001970869],"genre_scores_gemma":[0.9934625,0.004914213,0.000226927,0.00002600947,0.0004354521,0.000354658,0.0001171409,0.0001035517,0.0003595493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1344029,"threshold_uncertainty_score":0.99979,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007086941316279682,"score_gpt":0.2970514308342804,"score_spread":0.2899644895180007,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}